Showing results (531-540 of 552) with videos related to
Sort By:
Pageof 56
Lancet (London, England)|November 29, 2005
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trialA Keech, R J Simes, P Barter, et al.Diabetologia|April 26, 2008
Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in miceS Franckhauser, I Elias, V Rotter Sopasakis, et al.Diabetologia|July 17, 2012
Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitroV D'Esposito, F Passaretti, A Hammarstedt, et al.Journal of Glaucoma|November 2, 2020
Economic and Clinical Burden Associated With Intensification of Glaucoma Topical Therapy: A US Claims-based AnalysisAnik R Patel, Gail F Schwartz, Joanna H Campbell, et al.Journal of Glaucoma|October 10, 2021
Twenty-Four-Month Outcome of Gonioscopy-Assisted Transluminal Trabeculotomy (GATT) in Eyes With Prior Corneal Transplant SurgeryOluwatosin U Smith, Michelle R Butler, Davinder S Grover, et al.Clinical Ophthalmology (Auckland, N.Z.)|December 11, 2019
Early Results of Goniotomy with the Kahook Dual Blade, a Novel Device for the Treatment of GlaucomaHelen L Kornmann, Ronald L Fellman, William J Feuer, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 22, 2017
Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese menN Matikainen, S Söderlund, E Björnson, et al.The Journal of Clinical Investigation|February 15, 1997
Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defectM Lehto, T Tuomi, M M Mahtani, et al.Lancet (London, England)|November 9, 2007
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trialA C Keech, P Mitchell, P A Summanen, et al.Journal of Internal Medicine|May 27, 2017
Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesityM-R Taskinen, S Söderlund, L H Bogl, et al.Pageof 56